We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+24.54%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$8.03B
AUM Growth
+$752M
Cap. Flow
-$754M
Cap. Flow %
-9.4%
Top 10 Hldgs %
69.33%
Holding
70
New
6
Increased
6
Reduced
13
Closed
16

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$476M
2
ALGN icon
Align Technology
ALGN
+$197M
3
VIE
Viela Bio, Inc. Common Stock
VIE
+$116M
4
UBER icon
Uber
UBER
+$94.2M
5
KYNB
Kyntra Bio
KYNB
+$18.5M

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$258M
2
SE icon
Sea Limited
SE
+$258M
3
META icon
Meta Platforms (Facebook)
META
+$228M
4
JD icon
JD.com
JD
+$136M
5
TAL icon
TAL Education Group
TAL
+$119M

Sector Composition

Rank Sector Weight
1 Healthcare 34.79%
2 Consumer Discretionary 17.89%
3 Communication Services 16.91%
4 Technology 11.84%
5 Consumer Staples 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQ icon
1
iQIYI
IQ
$1.2B
$986M 12.28%
46,694,629
-3,821,559
-8% -$70.3M
ONC
2
BeOne Medicines Ltd
ONC
$33.9B
$907M 11.3%
5,472,259
ALGN icon
3
Align Technology
ALGN
$12.8B
$657M 8.18%
2,353,591
+788,091
+50% +$197M
TAL icon
4
TAL Education Group
TAL
$6B
$553M 6.89%
11,465,202
-2,762,349
-19% -$119M
ZM icon
5
Zoom
ZM
$26.7B
$471M 5.86%
+6,916,078
New +$476M
UBER icon
6
Uber
UBER
$143B
$461M 5.74%
15,501,624
+3,175,105
+26% +$94.2M
BABA icon
7
Alibaba
BABA
$275B
$420M 5.23%
1,979,716
-198,752
-9% -$37.3M
JD icon
8
JD.com
JD
$43.3B
$419M 5.23%
11,905,028
-4,214,741
-26% -$136M
ESGR
9
DELISTED
Enstar Group
ESGR
$362M 4.5%
1,747,840
PDD icon
10
Pinduoduo
PDD
$124B
$330M 4.11%
8,729,366
-2,417,249
-22% -$90.2M
CBPO
11
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$320M 3.99%
2,751,200
BILI icon
12
Bilibili
BILI
$7.8B
$190M 2.37%
10,215,355
-2,617,521
-20% -$42.5M
SE icon
13
Sea Limited
SE
$66.5B
$173M 2.15%
4,300,000
-7,657,037
-64% -$258M
KYNB
14
Kyntra Bio
KYNB
$28.2M
$170M 2.11%
158,231
+18,100
+13% +$18.5M
BBIO icon
15
BridgeBio Pharma
BBIO
$16.6B
$154M 1.92%
4,388,690
APLS
16
DELISTED
Apellis Pharmaceuticals
APLS
$143M 1.78%
4,678,289
MDLZ icon
17
Mondelez International
MDLZ
$84B
$140M 1.75%
2,546,564
VIE
18
DELISTED
Viela Bio, Inc. Common Stock
VIE
$125M 1.55%
+4,591,176
New +$116M
BPMC
19
DELISTED
Blueprint Medicines
BPMC
$121M 1.5%
1,504,599
+6,083
+0.4% +$455K
GOSS icon
20
Gossamer Bio
GOSS
$91.2M
$92.4M 1.15%
5,911,541
EDU icon
21
New Oriental
EDU
$9.03B
$73.1M 0.91%
603,208
-2,158,074
-78% -$258M
SNAP icon
22
Snap
SNAP
$8.06B
$72.9M 0.91%
4,465,885
MYOK
23
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$71.1M 0.89%
975,987
NXTC icon
24
NextCure
NXTC
$21.2M
$59.3M 0.74%
87,798
LN
25
DELISTED
LINE Corporation
LN
$55M 0.68%
1,121,357
-86,406
-7% -$3.7M

Similar funds

HHLR Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, HHLR Advisors held 70 positions worth $8.03B, up 10% from $7.27B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HHLR Advisors withdrew a net $754M in Q4 2019, closing 16 positions and reducing 13 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, HHLR Advisors opened a new position in Zoom worth $471M.

  • HHLR Advisors's largest Q4 2019 buy was Zoom: 6,916,078 shares worth $471M.
  • HHLR Advisors added most to Align Technology in Q4 2019, an estimated $197M increase.
  • HHLR Advisors's biggest Q4 2019 reduction was New Oriental, cutting an estimated $258M.
  • HHLR Advisors fully exited Meta Platforms (Facebook) in Q4 2019, selling an estimated $228M.
  • HHLR Advisors's ten largest holdings make up 69% of its $8.03B portfolio in Q4 2019.
  • HHLR Advisors opened 6 new positions and closed 16 in Q4 2019.
  • HHLR Advisors's portfolio value rose 10% quarter-over-quarter to $8.03B.

Based on HHLR Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.